Global Carrier Screening Market Size, Share, Trends, Industry Growth by Type (Expanded, Targeted Disease), by Technology (DNA Sequencing, PCR, Microarrays, Others), by Medical Condition, by End-User, by Region, and Forecast to 2028

Report ID: RCMA168 | Report Format: PDF + Excel | Starting Price: 2680/- USD |

The global carrier screening market size is expected to experience a robust CAGR of around 17% during the forecast period 2022 to 2028. The rising prevalence of genetic disorders such as cystic fibrosis, sickle cell anemia, and Marfan syndrome is a primary factor to drives market growth. According to the information shared by the Cystic Fibrosis Foundation, it is estimated that over 30,000 children and adults have cystic fibrosis in the United States. Furthermore, the rising awareness regarding early detection and prevention of diseases, the growing trend of personalized medicines, and the rising adoption of screening tests for genetic disorders are further anticipated to boost the market growth over the forecast period.

Furthermore, the increasing investment in research and development activities is expected to fuel the market growth. In 2018, the Cystic Fibrosis Foundation (CFF) announced to contribute the US $100 million to the Infection Research Initiative, a comprehensive approach to improving outcomes associated with infections through better detection, diagnosis, prevention, and treatment. Moreover, healthcare organizations in various countries are raising their funding for newborn screening to predict diseases.

Market Insights:

By technology, DNA sequencing is expected to hold the largest revenue share of the global market by 2028

The global carrier screening market is bifurcated into type, technology, medical condition, end-user, and geography. On the basis of technology, the market is further segmented into DNA sequencing, polymerase chain reaction, microarrays, and others. The DNA sequencing segment is accounted to hold a significant market share in 2020 and is expected to grow at the same trend over the forecast period. The rising prevalence of the chronic disease is one of the prominent factors to drive the segment growth. Furthermore, the continuous innovation in genetic analysis techniques is further anticipated to fuel the segment growth over the forecast period. On the flip side, the PCR segment is estimated to register the fastest CAGR over the forecast period.

By medical conditions, the pulmonary conditions dominated the global carrier screening market

On the basis of the medical conditions, the market is segmented into pulmonary conditions, hematological conditions, neurological conditions, and others. The pulmonary conditions segment dominated the global carrier screening market in 2020 and is expected to maintain its dominance over the forecast period. The rising prevalence of pulmonary diseases such as asthma, COPD, lung cancer, and pulmonary fibrosis is a major factor to drive the segment growth. As per the information shared by World Health Organization (WHO), it is estimated that 65 million people have moderate to severe COPD and around 3 million people die due to it every year. Furthermore, WHO says, around 334 million people suffer from asthma and it is the most common chronic disease found in children.

Carrier Screening Market Share

To know more about the market report, request sample papers

The carrier screening comprehensive study analyzes industry trends, market size, competitive analysis, and market forecast – 2022 to 2028. Research Corridor report provides detailed premium insight into the global market and reveals the potential revenue streams, commercial prospects, market drivers, challenges, opportunities, issues, and events affecting the industry. In addition, the report has a dedicated section covering market forecasts and analysis for leading geographies, profiles of major companies operating in the market and expert opinion obtained from interviews with industry executives and experts from prominent companies.

The carrier screening market research report presents the analysis of each segment from 2019 to 2028 considering 2020 as the base year for the research. The compounded annual growth rate (CAGR) for each respective segment is calculated for the forecast period from 2021 to 2027.

Historical & Forecast Period

  • 2019-20 – Historical Year
  • 2021 – Base Year
  • 2022-2028 – Forecast Period

Global Carrier Screening Market Segmentation:

Carrier Screening Market Segmentation by Type:

  • Expanded
    • Customized Panel Testing
    • Predesigned Panel Testing
  • Targeted Disease

Carrier Screening Market Segmentation by Technology:

  • DNA Sequencing
  • Polymerase Chain Reaction (PCR)
  • Microarrays
  • Others

Carrier Screening Market Segmentation by Medical Condition:

  • Pulmonary Conditions
  • Hematological Conditions
  • Neurological Conditions
  • Others

Carrier Screening Market Segmentation by End-User:

  • Hospitals
  • Reference Laboratories
  • Physician Offices & Clinics
  • Other

Carrier Screening Market Segmentation by Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Carrier Screening Market: Geographic Coverage

North America accounted to hold the largest market share of over 40% of the global market

Geographically, North America dominated the global carrier screening market in 2020 and is expected to hold the largest revenue share of over 40% of the market by the end of the analysis period. The rising prevalence of genetic disorders and the growing inclination towards early detection and prevention of diseases are some major factors to drive the market growth in the region. According to WHO, genetic disorders is one of the prominent factor responsible for newborn mortality in the United States. Furthermore, the increasing adoption of carrier screening and the rising demand for personalized medicines are further expected to fuel the market growth in North America.

Carrier Screening Market: Competitive Assessment

Some of the major market players operating in the global carrier screening market are Eurofins Scientific, Opko Health, Invitae Corporation, Autogenomics Inc., and Fulgent Genetics. Companies are exploring markets by expansion, new investment, and the introduction of new services, collaboration, and acquisitions as their preferred strategies. For instance, in July 2018, Myriad Genetics Inc. has acquired Counsyl, Inc. to strengthen its genetic test portfolio in the market. Players are exploring new geography through expansion and acquisition to gain a competitive advantage through joint synergy.

List of Key Companies:

  • Eurofins Scientific
  • Opko Health
  • Invitae Corporation
  • Autogenomics Inc.
  • Fulgent Genetics
  • Danaher Corporation
  • Myriad Genetics
  • Quest Diagnostics
  • Thermo Fisher Scientific
  • Illumina Inc.

Key Questions Answered by Carrier Screening Market Report

  • Global carrier screening market forecasts from 2022-2028
  • Regional market forecasts from 2022-2028 covering Asia-Pacific, North America, Europe, Middle East & Africa, and Latin America
  • Country-level forecasts from 2022-2028 covering 15 major countries from the regions as mentioned above
  • Carrier screening submarket forecasts from 2022-2028 covering the market by type, by technology, by medical condition, by end-user, and geography
  • Various industry models such as SWOT analysis, Value Chain Analysis about the market
  • Analysis of the key factors driving and restraining the growth of the global, regional, and country-level carrier screening markets from 2022-2028
  • Competitive Landscape and market positioning of top 10 players operating in the market
Carrier Screening Market
Table of Content:

1. Preface


1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.4. Assumptions

 

2. Executive Summary


2.1. Global Carrier Screening Market Portraiture
2.2. Global Carrier Screening Market, by Type, 2021 (USD Mn)
2.3. Global Carrier Screening Market, by Technology, 2021 (USD Mn)
2.4. Global Carrier Screening Market, by Medical Condition, 2021 (USD Mn)
2.5. Global Carrier Screening Market, by End-User, 2021 (USD Mn)
2.6. Global Carrier Screening Market, by Geography, 2021 (USD Mn)

 

3. Global Carrier Screening Market Analysis


3.1. Carrier Screening Market Overview
3.2. Market Inclination Insights
3.3. Market Dynamics
3.3.1. Drivers
3.3.2. Challenges
3.3.3. Opportunities
3.4. Attractive Investment Proposition
3.5. Competitive Analysis
3.6. Porter’s Five Force Analysis
3.6.1. Bargaining Power of Suppliers
3.6.2. Bargaining Power of Buyers
3.6.3. Threat of New Entrants
3.6.4. Threat of Substitutes
3.6.5. Degree of Competition
3.7. COVID-19 Impact Analysis

 

4. Global Carrier Screening Market By Type, 2019 – 2028 (USD Mn)


4.1. Overview
4.2. Expanded
4.2.1. Customized Panel Testing
4.2.2. Predesigned Panel Testing
4.3. Targeted Disease

 

5. Global Carrier Screening Market By Technology, 2019 – 2028 (USD Mn)


5.1. Overview
5.2. DNA Sequencing
5.3. Polymerase Chain Reaction (PCR)
5.4. Microarrays
5.5. Others

 

6. Global Carrier Screening Market By Medical Condition, 2019 – 2028 (USD Mn)


6.1. Overview
6.2. Pulmonary Conditions
6.3. Hematological Conditions
6.4. Neurological Conditions
6.5. Others

 

7. Global Carrier Screening Market By End-User, 2019 – 2028 (USD Mn)


7.1. Overview
7.2. Hospitals
7.3. Reference Laboratories
7.4. Physician Offices & Clinics
7.5. Other

 

8. North America Carrier Screening Market Analysis and Forecast, 2019 – 2028 (USD Mn)


8.1.1. Overview
8.1.2. North America Carrier Screening Market by Type (2019-2028 USD Mn)
8.1.3. North America Carrier Screening Market by Technology (2019-2028 USD Mn)
8.1.4. North America Carrier Screening Market by Medical Condition (2019-2028 USD Mn)
8.1.5. North America Carrier Screening Market by End-User (2019-2028 USD Mn)
8.1.6. North America Carrier Screening Market by Country (2019-2028 USD Mn)
8.1.6.1. U.S.
8.1.6.1.1. U.S. Carrier Screening Market by Type (2019-2028 USD Mn)
8.1.6.1.2. U.S. Carrier Screening Market by Technology (2019-2028 USD Mn)
8.1.6.1.3. U.S. Carrier Screening Market by Medical Condition (2019-2028 USD Mn)
8.1.6.1.4. U.S. Carrier Screening Market by End-User (2019-2028 USD Mn)
8.1.6.2. Canada
8.1.6.2.1. Canada Carrier Screening Market by Type (2019-2028 USD Mn)
8.1.6.2.2. Canada Carrier Screening Market by Technology (2019-2028 USD Mn)
8.1.6.2.3. Canada Carrier Screening Market by Medical Condition (2019-2028 USD Mn)
8.1.6.2.4. Canada Carrier Screening Market by End-User (2019-2028 USD Mn)

 

9. Europe Carrier Screening Market Analysis and Forecast, 2019 – 2028 (USD Mn)


9.1.1. Overview
9.1.2. Europe Carrier Screening Market by Type (2019-2028 USD Mn)
9.1.3. Europe Carrier Screening Market by Technology (2019-2028 USD Mn)
9.1.4. Europe Carrier Screening Market by Medical Condition (2019-2028 USD Mn)
9.1.5. Europe Carrier Screening Market by End-User (2019-2028 USD Mn)
9.1.6. Europe Carrier Screening Market by Country (2019-2028 USD Mn)
9.1.6.1. Germany
9.1.6.1.1. Germany Carrier Screening Market by Type (2019-2028 USD Mn)
9.1.6.1.2. Germany Carrier Screening Market by Technology (2019-2028 USD Mn)
9.1.6.1.3. Germany Carrier Screening Market by Medical Condition (2019-2028 USD Mn)
9.1.6.1.4. Germany Carrier Screening Market by End-User (2019-2028 USD Mn)
9.1.6.2. U.K.
9.1.6.2.1. U.K. Carrier Screening Market by Type (2019-2028 USD Mn)
9.1.6.2.2. U.K. Carrier Screening Market by Technology (2019-2028 USD Mn)
9.1.6.2.3. U.K. Carrier Screening Market by Medical Condition (2019-2028 USD Mn)
9.1.6.2.4. U.K. Carrier Screening Market by End-User (2019-2028 USD Mn)
9.1.6.3. France
9.1.6.3.1. France Carrier Screening Market by Type (2019-2028 USD Mn)
9.1.6.3.2. France Carrier Screening Market by Technology (2019-2028 USD Mn)
9.1.6.3.3. France Carrier Screening Market by Medical Condition (2019-2028 USD Mn)
9.1.6.3.4. France Carrier Screening Market by End-User (2019-2028 USD Mn)
9.1.6.4. Italy
9.1.6.4.1. Italy Carrier Screening Market by Type (2019-2028 USD Mn)
9.1.6.4.2. Italy Carrier Screening Market by Technology (2019-2028 USD Mn)
9.1.6.4.3. Italy Carrier Screening Market by Medical Condition (2019-2028 USD Mn)
9.1.6.4.4. Italy Carrier Screening Market by End-User (2019-2028 USD Mn)
9.1.6.5. Rest of Europe
9.1.6.5.1. Rest of Europe Carrier Screening Market by Type (2019-2028 USD Mn)
9.1.6.5.2. Rest of Europe Carrier Screening Market by Technology (2019-2028 USD Mn)
9.1.6.5.3. Rest of Europe Carrier Screening Market by Medical Condition (2019-2028 USD Mn)
9.1.6.5.4. Rest of Europe Carrier Screening Market by End-User (2019-2028 USD Mn)

 

10. Asia Pacific Carrier Screening Market Analysis and Forecast, 2019 – 2028 (USD Mn)


10.1.1. Overview
10.1.2. Asia Pacific Carrier Screening Market by Type (2019-2028 USD Mn)
10.1.3. Asia Pacific Carrier Screening Market by Technology (2019-2028 USD Mn)
10.1.4. Asia Pacific Carrier Screening Market by End-User (2019-2028 USD Mn)
10.1.5. Asia Pacific Carrier Screening Market by Medical Condition (2019-2028 USD Mn)
10.1.6. Asia Pacific Carrier Screening Market by Country (2019-2028 USD Mn)
10.1.6.1. China
10.1.6.1.1. China Carrier Screening Market by Type (2019-2028 USD Mn)
10.1.6.1.2. China Carrier Screening Market by Technology (2019-2028 USD Mn)
10.1.6.1.3. China Carrier Screening Market by Medical Condition (2019-2028 USD Mn)
10.1.6.1.4. China Carrier Screening Market by End-User (2019-2028 USD Mn)
10.1.6.2. Japan
10.1.6.2.1. Japan Carrier Screening Market by Type (2019-2028 USD Mn)
10.1.6.2.2. Japan Carrier Screening Market by Technology (2019-2028 USD Mn)
10.1.6.2.3. Japan Carrier Screening Market by Medical Condition (2019-2028 USD Mn)
10.1.6.2.4. Japan Carrier Screening Market by End-User (2019-2028 USD Mn)
10.1.6.3. Rest of Asia Pacific
10.1.6.3.1. Rest of Asia Pacific Carrier Screening Market by Type (2019-2028 USD Mn)
10.1.6.3.2. Rest of Asia Pacific Carrier Screening Market by Technology (2019-2028 USD Mn)
10.1.6.3.3. Rest of Asia Pacific Carrier Screening Market by Medical Condition (2019-2028 USD Mn)
10.1.6.3.4. Rest of Asia Pacific Carrier Screening Market by End-User (2019-2028 USD Mn)

 

11. Latin America (LATAM) Carrier Screening Market Analysis and Forecast, 2019 – 2028 (USD Mn)


11.1.1. Overview
11.1.2. Latin America Carrier Screening Market by Type (2019-2028 USD Mn)
11.1.3. Latin America Carrier Screening Market by Technology (2019-2028 USD Mn)
11.1.4. Latin America Carrier Screening Market by Medical Condition (2019-2028 USD Mn)
11.1.5. Latin America Carrier Screening Market by End-User (2019-2028 USD Mn)
11.1.6. Latin America Carrier Screening Market by Country (2019-2028 USD Mn)
11.1.6.1. Brazil
11.1.6.1.1. Brazil Carrier Screening Market by Type (2019-2028 USD Mn)
11.1.6.1.2. Brazil Carrier Screening Market by Technology (2019-2028 USD Mn)
11.1.6.1.3. Brazil Carrier Screening Market by Medical Condition (2019-2028 USD Mn)
11.1.6.1.4. Brazil Carrier Screening Market by End-User (2019-2028 USD Mn)
11.1.6.2. Mexico
11.1.6.2.1. Mexico Carrier Screening Market by Type (2019-2028 USD Mn)
11.1.6.2.2. Mexico Carrier Screening Market by Technology (2019-2028 USD Mn)
11.1.6.2.3. Mexico Carrier Screening Market by Medical Condition (2019-2028 USD Mn)
11.1.6.2.4. Mexico Carrier Screening Market by End-User (2019-2028 USD Mn)
11.1.6.3. Rest of Latin America
11.1.6.3.1. Rest of Latin America Carrier Screening Market by Type (2019-2028 USD Mn)
11.1.6.3.2. Rest of Latin America Carrier Screening Market by Technology (2019-2028 USD Mn)
11.1.6.3.3. Rest of Latin America Carrier Screening Market by Medical Condition (2019-2028 USD Mn)
11.1.6.3.4. Rest of Latin America Carrier Screening Market by End-User (2019-2028 USD Mn)

 

12. Middle East and Africa Carrier Screening Market Analysis and Forecast, 2019 – 2028 (USD Mn)


12.1.1. Overview
12.1.2. MEA Carrier Screening Market by Type (2019-2028 USD Mn)
12.1.3. MEA Carrier Screening Market by Technology (2019-2028 USD Mn)
12.1.4. MEA Carrier Screening Market by Medical Condition (2019-2028 USD Mn)
12.1.5. MEA Carrier Screening Market by End-User (2019-2028 USD Mn)
12.1.6. Middle East and Africa Carrier Screening Market, by Country (2019-2028 USD Mn)
12.1.6.1. GCC
12.1.6.1.1. GCC Carrier Screening Market by Type (2019-2028 USD Mn)
12.1.6.1.2. GCC Carrier Screening Market by Technology (2019-2028 USD Mn)
12.1.6.1.3. GCC Carrier Screening Market by Medical Condition (2019-2028 USD Mn)
12.1.6.1.4. GCC Carrier Screening Market by End-User (2019-2028 USD Mn)
12.1.6.2. South Africa
12.1.6.2.1. South Africa Carrier Screening Market by Type (2019-2028 USD Mn)
12.1.6.2.2. South Africa Carrier Screening Market by Technology (2019-2028 USD Mn)
12.1.6.2.3. South Africa Carrier Screening Market by Medical Condition (2019-2028 USD Mn)
12.1.6.2.4. South Africa Carrier Screening Market by End-User (2019-2028 USD Mn)
12.1.6.3. Rest of MEA
12.1.6.3.1. Rest of MEA Carrier Screening Market by Type (2019-2028 USD Mn)
12.1.6.3.2. Rest of MEA Carrier Screening Market by Technology (2019-2028 USD Mn)
12.1.6.3.3. Rest of MEA Carrier Screening Market by Medical Condition (2019-2028 USD Mn)
12.1.6.3.4. Rest of MEA Carrier Screening Market by End-User (2019-2028 USD Mn)

 

13. Company Profiles


13.1. Eurofins Scientific
13.1.1. Business Description
13.1.2. Financial Health and Budget Allocation
13.1.3. Product Positions/Portfolio
13.1.4. Recent Development
13.1.5. SWOT Analysis
13.2. Opko Health
13.2.1. Business Description
13.2.2. Financial Health and Budget Allocation
13.2.3. Product Positions/Portfolio
13.2.4. Recent Development
13.2.5. SWOT Analysis
13.3. Invitae Corporation
13.3.1. Business Description
13.3.2. Financial Health and Budget Allocation
13.3.3. Product Positions/Portfolio
13.3.4. Recent Development
13.3.5. SWOT Analysis
13.4. Autogenomics Inc.
13.4.1. Business Description
13.4.2. Financial Health and Budget Allocation
13.4.3. Product Positions/Portfolio
13.4.4. Recent Development
13.4.5. SWOT Analysis
13.5. Fulgent Genetics
13.5.1. Business Description
13.5.2. Financial Health and Budget Allocation
13.5.3. Product Positions/Portfolio
13.5.4. Recent Development
13.5.5. SWOT Analysis
13.6. Danaher Corporation
13.6.1. Business Description
13.6.2. Financial Health and Budget Allocation
13.6.3. Product Positions/Portfolio
13.6.4. Recent Development
13.6.5. SWOT Analysis
13.7. Myriad Genetics
13.7.1. Business Description
13.7.2. Financial Health and Budget Allocation
13.7.3. Product Positions/Portfolio
13.7.4. Recent Development
13.7.5. SWOT Analysis
13.8. Quest Diagnostics
13.8.1. Business Description
13.8.2. Financial Health and Budget Allocation
13.8.3. Product Positions/Portfolio
13.8.4. Recent Development
13.8.5. SWOT Analysis
13.9. Thermo Fisher Scientific
13.9.1. Business Description
13.9.2. Financial Health and Budget Allocation
13.9.3. Product Positions/Portfolio
13.9.4. Recent Development
13.9.5. SWOT Analysis
13.10. Illumina Inc.
13.10.1. Business Description
13.10.2. Financial Health and Budget Allocation
13.10.3. Product Positions/Portfolio
13.10.4. Recent Development
13.10.5. SWOT Analysis
Fill the given form to inquiry before buying for Global Carrier Screening Market Size, Share, Trends, Industry Growth by Type (Expanded, Targeted Disease), by Technology (DNA Sequencing, PCR, Microarrays, Others), by Medical Condition, by End-User, by Region, and Forecast to 2028 Market Report

(Additional country analysis and conmapny analysis will be added according to the request, we provide free report customization)
(Report covers the impact of COVID-19 on the market)

Request Report Sample
Inquiry Before Buying


Select License Type
$ 2680/- Single User License
$ 4800/- Multi User License
$ 6800/- Corporate License

Paypal Certified Payment
Why To Choose Us:
  • Markets in over 100+ countries analyzed granularly
  • 35% of our total client are returning clients
  • 1000+ customers globally
  • 100+ paid data sources mined to bring cutting-edge insights
  • 24x5 availability - we are always there when you need us
  • "Free of Cost Report Customization" is available
  • Request a regional report at Best Price
  • Our expert team will assist you with all research need and customization
  • Our expert research analysts will resolve your every query before and after purchasing the report

Impacts of COVID-19
COVID-19 Impact on the Global Carrier Screening Market Size, Share, Trends, Industry Growth by Type (Expanded, Targeted Disease), by Technology (DNA Sequencing, PCR, Microarrays, Others), by Medical Condition, by End-User, by Region, and Forecast to 2028 Market

Latest Market Insights

Our Clients